Cases of cancer among UK men and women aged 35-69 years have seen a modest rise over the last quarter of a century, but there has also been a substantial decline in death rates, finds a study published by The BMJ today.
Mar 13, 2024
0
0
Research from Edith Cowan University (ECU) has found that intrauterine exposure to diabetes could be a crucial factor in the mental and psychomotor development of children, particularly those younger than 12 months.
Mar 13, 2024
0
11
There are two statistics that Dr. Rachel Issaka would like people to seriously consider:
Mar 13, 2024
0
0
Intermittent fasting has become a popular dietary approach to help people lose or manage their weight. It has also been promoted as a way to reset metabolism, control chronic disease, slow aging and improve overall health.
Mar 12, 2024
0
0
A collaborative study between a bariatric and transplant surgery team has introduced new hope for patients suffering from end-stage renal disease (ESRD) who are also struggling with obesity. The study authors explored the ...
Mar 12, 2024
0
0
People have been using salt since the dawn of civilization to process, preserve and enhance foods. In ancient Rome, salt was so central to commerce that soldiers were paid their "salarium," or salaries, in salt, for instance.
Mar 12, 2024
0
17
A viral trend on TikTok has users sharing generational myths their parents told them. From how drinking water at night can cause nightmares to how—if swallowed—chewing gum can stay in your stomach for seven years. Health ...
Mar 11, 2024
0
9
An experimental new weight loss pill from Danish pharmaceutical giant Novo Nordisk could be twice as effective as its blockbuster Ozempic and Wegovy jabs, early results from a small trial have suggested, sending the firm's ...
Mar 8, 2024
0
1
Social media is obsessed with the type 2 diabetes drug Ozempic. But Ozempic's ability to control blood sugar isn't the reason it's so popular online. Instead, the drug is trending because it has been shown in clinical trials ...
Mar 7, 2024
0
0
Safety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study ...
Mar 6, 2024
0
0
